APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepatitis A Virus Cellular Receptor 2

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hepatitis A Virus Cellular Receptor 2 Industry Growth and Trends Forecast to 2032

19 December 2025100 pages

Choose your research edition.

Industry ResearchHepatitis A Virus Cellular Receptor 2 Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatitis A Virus Cellular Receptor 2 Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Hepatitis A Virus Cellular Receptor 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatitis A Virus Cellular Receptor 2 Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatitis A Virus Cellular Receptor 2 Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

According to APO Research, the global Hepatitis A Virus Cellular Receptor 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hepatitis A Virus Cellular Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hepatitis A Virus Cellular Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hepatitis A Virus Cellular Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Hepatitis A Virus Cellular Receptor 2 market include Aurigene Discovery Technologies Ltd, BeiGene Ltd, Enumeral Biomedical Holdings Inc, Incyte Corp, Interprotein Corp, Jounce Therapeutics Inc, Merus NV, Novartis AG and Sorrento Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hepatitis A Virus Cellular Receptor 2 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hepatitis A Virus Cellular Receptor 2 market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hepatitis A Virus Cellular Receptor 2 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hepatitis A Virus Cellular Receptor 2.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Hepatitis A Virus Cellular Receptor 2 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hepatitis A Virus Cellular Receptor 2 Market by Company

Aurigene Discovery Technologies Ltd

BeiGene Ltd

Enumeral Biomedical Holdings Inc

Incyte Corp

Interprotein Corp

Jounce Therapeutics Inc

Merus NV

Novartis AG

Sorrento Therapeutics Inc

Sutro Biopharma Inc

Tesaro Inc

Trellis Bioscience Inc

Eli Lilly and Co

Hepatitis A Virus Cellular Receptor 2 Segment by Type

CA-170

CA-327

ENUM-005

IMM-1802

LY-3321367

MCLA-134

Others

Hepatitis A Virus Cellular Receptor 2 Segment by Application

Colon Cancer

Myelodysplastic

Non-Small Cell Lung Cancer

Others

Hepatitis A Virus Cellular Receptor 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis A Virus Cellular Receptor 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatitis A Virus Cellular Receptor 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis A Virus Cellular Receptor 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Hepatitis A Virus Cellular Receptor 2 companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Hepatitis A Virus Cellular Receptor 2 Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Hepatitis A Virus Cellular Receptor 2 Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Region (2021-2026) Table 4. Global Hepatitis A Virus Cellular Receptor 2 Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Region (2027-2032) Table 6. Global Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Hepatitis A Virus Cellular Receptor 2 Market Size Share by Type (2021-2026) Table 9. Global Hepatitis A Virus Cellular Receptor 2 Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Hepatitis A Virus Cellular Receptor 2 Market Size Share Forecasted by Type (2027-2032) Table 11. North America Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Hepatitis A Virus Cellular Receptor 2 Market Size Share by Application (2021-2026) Table 24. Global Hepatitis A Virus Cellular Receptor 2 Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Hepatitis A Virus Cellular Receptor 2 Market Size Share Forecasted by Application (2027-2032) Table 26. North America Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Hepatitis A Virus Cellular Receptor 2 Industry Trends Table 37. Hepatitis A Virus Cellular Receptor 2 Industry Drivers Table 38. Hepatitis A Virus Cellular Receptor 2 Industry Opportunities and Challenges Table 39. Hepatitis A Virus Cellular Receptor 2 Industry Restraints Table 40. Global Hepatitis A Virus Cellular Receptor 2 Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Company (2021-2026) Table 42. Global Hepatitis A Virus Cellular Receptor 2 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Hepatitis A Virus Cellular Receptor 2 Key Company Headquarters & Area Served Table 44. Global Hepatitis A Virus Cellular Receptor 2 Company, Product Type & Application Table 45. Global Hepatitis A Virus Cellular Receptor 2 Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Hepatitis A Virus Cellular Receptor 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Aurigene Discovery Technologies Ltd Company Information Table 49. Aurigene Discovery Technologies Ltd Business Overview Table 50. Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 52. Aurigene Discovery Technologies Ltd Recent Development Table 53. BeiGene Ltd Company Information Table 54. BeiGene Ltd Business Overview Table 55. BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 57. BeiGene Ltd Recent Development Table 58. Enumeral Biomedical Holdings Inc Company Information Table 59. Enumeral Biomedical Holdings Inc Business Overview Table 60. Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 62. Enumeral Biomedical Holdings Inc Recent Development Table 63. Incyte Corp Company Information Table 64. Incyte Corp Business Overview Table 65. Incyte Corp Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Incyte Corp Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 67. Incyte Corp Recent Development Table 68. Interprotein Corp Company Information Table 69. Interprotein Corp Business Overview Table 70. Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 72. Interprotein Corp Recent Development Table 73. Jounce Therapeutics Inc Company Information Table 74. Jounce Therapeutics Inc Business Overview Table 75. Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 77. Jounce Therapeutics Inc Recent Development Table 78. Merus NV Company Information Table 79. Merus NV Business Overview Table 80. Merus NV Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Merus NV Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 82. Merus NV Recent Development Table 83. Novartis AG Company Information Table 84. Novartis AG Business Overview Table 85. Novartis AG Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Novartis AG Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 87. Novartis AG Recent Development Table 88. Sorrento Therapeutics Inc Company Information Table 89. Sorrento Therapeutics Inc Business Overview Table 90. Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 92. Sorrento Therapeutics Inc Recent Development Table 93. Sutro Biopharma Inc Company Information Table 94. Sutro Biopharma Inc Business Overview Table 95. Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 97. Sutro Biopharma Inc Recent Development Table 98. Tesaro Inc Company Information Table 99. Tesaro Inc Business Overview Table 100. Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 102. Tesaro Inc Recent Development Table 103. Trellis Bioscience Inc Company Information Table 104. Trellis Bioscience Inc Business Overview Table 105. Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 107. Trellis Bioscience Inc Recent Development Table 108. Eli Lilly and Co Company Information Table 109. Eli Lilly and Co Business Overview Table 110. Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Product Portfolio Table 112. Eli Lilly and Co Recent Development Table 113. North America Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2021-2026) Table 116. North America Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Hepatitis A Virus Cellular Receptor 2 Market Share Forecast by Country (2027-2032) Table 118. Europe Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2021-2026) Table 121. Europe Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Hepatitis A Virus Cellular Receptor 2 Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2021-2026) Table 126. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Share Forecast by Country (2027-2032) Table 128. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2021-2026) Table 131. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Hepatitis A Virus Cellular Receptor 2 Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2021-2026) Table 136. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Hepatitis A Virus Cellular Receptor 2 Product Image Figure 3. Global Hepatitis A Virus Cellular Receptor 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Hepatitis A Virus Cellular Receptor 2 Market Size (2021-2032) & (US$ Million) Figure 5. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Region: 2025 VS 2032 Figure 6. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Region (2021-2032) Figure 7. North America Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. CA-170 Image Figure 13. Global CA-170 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. CA-327 Image Figure 15. Global CA-327 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. ENUM-005 Image Figure 17. Global ENUM-005 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. IMM-1802 Image Figure 19. Global IMM-1802 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. LY-3321367 Image Figure 21. Global LY-3321367 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. MCLA-134 Image Figure 23. Global MCLA-134 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Others Image Figure 25. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Global Hepatitis A Virus Cellular Receptor 2 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 27. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Type 2025 VS 2032 Figure 28. North America Hepatitis A Virus Cellular Receptor 2 Market Size Share by Type (2021-2032) Figure 29. Europe Hepatitis A Virus Cellular Receptor 2 Market Size Share by Type (2021-2032) Figure 30. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Share by Type (2021-2032) Figure 31. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size Share by Type (2021-2032) Figure 32. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Size Share by Type (2021-2032) Figure 33. Colon Cancer Image Figure 34. Global Colon Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Myelodysplastic Image Figure 36. Global Myelodysplastic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Non-Small Cell Lung Cancer Image Figure 38. Global Non-Small Cell Lung Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Others Image Figure 40. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Global Hepatitis A Virus Cellular Receptor 2 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Application 2025 VS 2032 Figure 43. North America Hepatitis A Virus Cellular Receptor 2 Market Size Share by Application (2021-2032) Figure 44. Europe Hepatitis A Virus Cellular Receptor 2 Market Size Share by Application (2021-2032) Figure 45. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Share by Application (2021-2032) Figure 46. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size Share by Application (2021-2032) Figure 47. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Size Share by Application (2021-2032) Figure 48. Global Top 5 and 10 Hepatitis A Virus Cellular Receptor 2 Players Market Share by Revenue in 2025 Figure 49. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 50. North America Hepatitis A Virus Cellular Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. North America Hepatitis A Virus Cellular Receptor 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. North America Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2021-2032) Figure 53. Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Hepatitis A Virus Cellular Receptor 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2021-2032) Figure 56. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2021-2032) Figure 59. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Hepatitis A Virus Cellular Receptor 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2021-2032) Figure 62. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2021-2032) Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • CA-170
  • CA-327
  • ENUM-005
  • IMM-1802
  • LY-3321367
  • MCLA-134
  • Others
Applications
  • Colon Cancer
  • Myelodysplastic
  • Non-Small Cell Lung Cancer
  • Others
Companies covered
  • Aurigene Discovery Technologies Ltd
  • BeiGene Ltd
  • Enumeral Biomedical Holdings Inc
  • Incyte Corp
  • Interprotein Corp
  • Jounce Therapeutics Inc
  • Merus NV
  • Novartis AG
  • Sorrento Therapeutics Inc
  • Sutro Biopharma Inc
  • Tesaro Inc
  • Trellis Bioscience Inc
  • Eli Lilly and Co

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Hepatitis A Virus Cellular Receptor 2 Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Region (2021-2032)
  5. 1.4.1 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Region (2021-2026)
  6. 1.4.2 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Region (2027-2032)
  7. 1.5 Key Regions Hepatitis A Virus Cellular Receptor 2 Market Size (2021-2032)
  8. 1.5.1 North America Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (2021-2032)
2 Hepatitis A Virus Cellular Receptor 2 Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 CA-170
  3. 2.1.2 CA-327
  4. 2.1.3 ENUM-005
  5. 2.1.4 IMM-1802
  6. 2.1.5 LY-3321367
  7. 2.1.6 MCLA-134
  8. 2.1.7 Others
  9. 2.2 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Type
  10. 2.2.1 Global Hepatitis A Virus Cellular Receptor 2 Market Size Overview by Type (2021-2032)
  11. 2.2.2 Global Hepatitis A Virus Cellular Receptor 2 Historic Market Size Review by Type (2021-2026)
  12. 2.2.3 Global Hepatitis A Virus Cellular Receptor 2 Market Size Forecasted by Type (2027-2032)
  13. 2.3 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Regions
  14. 2.3.1 North America Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2021-2026)
  15. 2.3.2 Europe Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2021-2026)
  16. 2.3.3 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2021-2026)
  17. 2.3.4 South America Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2021-2026)
  18. 2.3.5 Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Type (2021-2026)
3 Hepatitis A Virus Cellular Receptor 2 Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Colon Cancer
  3. 3.1.2 Myelodysplastic
  4. 3.1.3 Non-Small Cell Lung Cancer
  5. 3.1.4 Others
  6. 3.2 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Application
  7. 3.2.1 Global Hepatitis A Virus Cellular Receptor 2 Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Hepatitis A Virus Cellular Receptor 2 Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Hepatitis A Virus Cellular Receptor 2 Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Regions
  11. 3.3.1 North America Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Hepatitis A Virus Cellular Receptor 2 Industry Trends
  2. 4.2 Hepatitis A Virus Cellular Receptor 2 Industry Drivers
  3. 4.3 Hepatitis A Virus Cellular Receptor 2 Industry Opportunities and Challenges
  4. 4.4 Hepatitis A Virus Cellular Receptor 2 Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Hepatitis A Virus Cellular Receptor 2 Revenue (2021-2026)
  2. 5.2 Global Hepatitis A Virus Cellular Receptor 2 Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Hepatitis A Virus Cellular Receptor 2 Key Company Headquarters & Area Served
  4. 5.4 Global Hepatitis A Virus Cellular Receptor 2 Company, Product Type & Application
  5. 5.5 Global Hepatitis A Virus Cellular Receptor 2 Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Hepatitis A Virus Cellular Receptor 2 Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Hepatitis A Virus Cellular Receptor 2 Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Hepatitis A Virus Cellular Receptor 2 Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Aurigene Discovery Technologies Ltd
  2. 6.1.1 Aurigene Discovery Technologies Ltd Company Information
  3. 6.1.2 Aurigene Discovery Technologies Ltd Business Overview
  4. 6.1.3 Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  6. 6.1.5 Aurigene Discovery Technologies Ltd Recent Developments
  7. 6.2 BeiGene Ltd
  8. 6.2.1 BeiGene Ltd Company Information
  9. 6.2.2 BeiGene Ltd Business Overview
  10. 6.2.3 BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  12. 6.2.5 BeiGene Ltd Recent Developments
  13. 6.3 Enumeral Biomedical Holdings Inc
  14. 6.3.1 Enumeral Biomedical Holdings Inc Company Information
  15. 6.3.2 Enumeral Biomedical Holdings Inc Business Overview
  16. 6.3.3 Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  18. 6.3.5 Enumeral Biomedical Holdings Inc Recent Developments
  19. 6.4 Incyte Corp
  20. 6.4.1 Incyte Corp Company Information
  21. 6.4.2 Incyte Corp Business Overview
  22. 6.4.3 Incyte Corp Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Incyte Corp Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  24. 6.4.5 Incyte Corp Recent Developments
  25. 6.5 Interprotein Corp
  26. 6.5.1 Interprotein Corp Company Information
  27. 6.5.2 Interprotein Corp Business Overview
  28. 6.5.3 Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  30. 6.5.5 Interprotein Corp Recent Developments
  31. 6.6 Jounce Therapeutics Inc
  32. 6.6.1 Jounce Therapeutics Inc Company Information
  33. 6.6.2 Jounce Therapeutics Inc Business Overview
  34. 6.6.3 Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  36. 6.6.5 Jounce Therapeutics Inc Recent Developments
  37. 6.7 Merus NV
  38. 6.7.1 Merus NV Company Information
  39. 6.7.2 Merus NV Business Overview
  40. 6.7.3 Merus NV Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Merus NV Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  42. 6.7.5 Merus NV Recent Developments
  43. 6.8 Novartis AG
  44. 6.8.1 Novartis AG Company Information
  45. 6.8.2 Novartis AG Business Overview
  46. 6.8.3 Novartis AG Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Novartis AG Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  48. 6.8.5 Novartis AG Recent Developments
  49. 6.9 Sorrento Therapeutics Inc
  50. 6.9.1 Sorrento Therapeutics Inc Company Information
  51. 6.9.2 Sorrento Therapeutics Inc Business Overview
  52. 6.9.3 Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  54. 6.9.5 Sorrento Therapeutics Inc Recent Developments
  55. 6.10 Sutro Biopharma Inc
  56. 6.10.1 Sutro Biopharma Inc Company Information
  57. 6.10.2 Sutro Biopharma Inc Business Overview
  58. 6.10.3 Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  60. 6.10.5 Sutro Biopharma Inc Recent Developments
  61. 6.11 Tesaro Inc
  62. 6.11.1 Tesaro Inc Company Information
  63. 6.11.2 Tesaro Inc Business Overview
  64. 6.11.3 Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  66. 6.11.5 Tesaro Inc Recent Developments
  67. 6.12 Trellis Bioscience Inc
  68. 6.12.1 Trellis Bioscience Inc Company Information
  69. 6.12.2 Trellis Bioscience Inc Business Overview
  70. 6.12.3 Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  72. 6.12.5 Trellis Bioscience Inc Recent Developments
  73. 6.13 Eli Lilly and Co
  74. 6.13.1 Eli Lilly and Co Company Information
  75. 6.13.2 Eli Lilly and Co Business Overview
  76. 6.13.3 Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Product Portfolio
  78. 6.13.5 Eli Lilly and Co Recent Developments
7 North America
  1. 7.1 North America Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2021-2026)
  3. 7.3 North America Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2021-2026)
  3. 8.3 Europe Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2021-2026)
  3. 10.3 South America Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst